The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hematology Therapies Market Research Report 2025
Synopsis
Hematology is a branch of medicine concerned with the study of blood, blood disease and the organs involved in forming blood.
The global Hematology Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hematology Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Therapies.
Report Scope
The Hematology Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hematology Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Bio-Rad Laboratories
Roche
HORIBA
Beckman Coulter
Bayer
Sysmex
Ortho Clinical Diagnostic
Siemens Healthineers
HemoCue
Boule Diagnostics
EKF Diagnostics
Drew Scientific
Mindray Medical
Segment by Type
Hematology Instruments
Hematology Consumables
Segment by Application
Diagnostic Laboratories
Hospitals and Clinics
Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematology Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hematology is a branch of medicine concerned with the study of blood, blood disease and the organs involved in forming blood.
The global Hematology Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hematology Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Therapies.
Report Scope
The Hematology Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hematology Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Bio-Rad Laboratories
Roche
HORIBA
Beckman Coulter
Bayer
Sysmex
Ortho Clinical Diagnostic
Siemens Healthineers
HemoCue
Boule Diagnostics
EKF Diagnostics
Drew Scientific
Mindray Medical
Segment by Type
Hematology Instruments
Hematology Consumables
Segment by Application
Diagnostic Laboratories
Hospitals and Clinics
Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematology Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematology Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hematology Instruments
1.2.3 Hematology Consumables
1.3 Market by Application
1.3.1 Global Hematology Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals and Clinics
1.3.4 Academic Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hematology Therapies Market Perspective (2019-2030)
2.2 Hematology Therapies Growth Trends by Region
2.2.1 Global Hematology Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hematology Therapies Historic Market Size by Region (2019-2024)
2.2.3 Hematology Therapies Forecasted Market Size by Region (2025-2030)
2.3 Hematology Therapies Market Dynamics
2.3.1 Hematology Therapies Industry Trends
2.3.2 Hematology Therapies Market Drivers
2.3.3 Hematology Therapies Market Challenges
2.3.4 Hematology Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hematology Therapies Players by Revenue
3.1.1 Global Top Hematology Therapies Players by Revenue (2019-2024)
3.1.2 Global Hematology Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Hematology Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hematology Therapies Revenue
3.4 Global Hematology Therapies Market Concentration Ratio
3.4.1 Global Hematology Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematology Therapies Revenue in 2023
3.5 Hematology Therapies Key Players Head office and Area Served
3.6 Key Players Hematology Therapies Product Solution and Service
3.7 Date of Enter into Hematology Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hematology Therapies Breakdown Data by Type
4.1 Global Hematology Therapies Historic Market Size by Type (2019-2024)
4.2 Global Hematology Therapies Forecasted Market Size by Type (2025-2030)
5 Hematology Therapies Breakdown Data by Application
5.1 Global Hematology Therapies Historic Market Size by Application (2019-2024)
5.2 Global Hematology Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hematology Therapies Market Size (2019-2030)
6.2 North America Hematology Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hematology Therapies Market Size by Country (2019-2024)
6.4 North America Hematology Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hematology Therapies Market Size (2019-2030)
7.2 Europe Hematology Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hematology Therapies Market Size by Country (2019-2024)
7.4 Europe Hematology Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hematology Therapies Market Size (2019-2030)
8.2 Asia-Pacific Hematology Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hematology Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific Hematology Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hematology Therapies Market Size (2019-2030)
9.2 Latin America Hematology Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hematology Therapies Market Size by Country (2019-2024)
9.4 Latin America Hematology Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hematology Therapies Market Size (2019-2030)
10.2 Middle East & Africa Hematology Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hematology Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa Hematology Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Hematology Therapies Introduction
11.1.4 Abbott Laboratories Revenue in Hematology Therapies Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Hematology Therapies Introduction
11.2.4 Bio-Rad Laboratories Revenue in Hematology Therapies Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Hematology Therapies Introduction
11.3.4 Roche Revenue in Hematology Therapies Business (2019-2024)
11.3.5 Roche Recent Development
11.4 HORIBA
11.4.1 HORIBA Company Detail
11.4.2 HORIBA Business Overview
11.4.3 HORIBA Hematology Therapies Introduction
11.4.4 HORIBA Revenue in Hematology Therapies Business (2019-2024)
11.4.5 HORIBA Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Detail
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Hematology Therapies Introduction
11.5.4 Beckman Coulter Revenue in Hematology Therapies Business (2019-2024)
11.5.5 Beckman Coulter Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Hematology Therapies Introduction
11.6.4 Bayer Revenue in Hematology Therapies Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 Sysmex
11.7.1 Sysmex Company Detail
11.7.2 Sysmex Business Overview
11.7.3 Sysmex Hematology Therapies Introduction
11.7.4 Sysmex Revenue in Hematology Therapies Business (2019-2024)
11.7.5 Sysmex Recent Development
11.8 Ortho Clinical Diagnostic
11.8.1 Ortho Clinical Diagnostic Company Detail
11.8.2 Ortho Clinical Diagnostic Business Overview
11.8.3 Ortho Clinical Diagnostic Hematology Therapies Introduction
11.8.4 Ortho Clinical Diagnostic Revenue in Hematology Therapies Business (2019-2024)
11.8.5 Ortho Clinical Diagnostic Recent Development
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Detail
11.9.2 Siemens Healthineers Business Overview
11.9.3 Siemens Healthineers Hematology Therapies Introduction
11.9.4 Siemens Healthineers Revenue in Hematology Therapies Business (2019-2024)
11.9.5 Siemens Healthineers Recent Development
11.10 HemoCue
11.10.1 HemoCue Company Detail
11.10.2 HemoCue Business Overview
11.10.3 HemoCue Hematology Therapies Introduction
11.10.4 HemoCue Revenue in Hematology Therapies Business (2019-2024)
11.10.5 HemoCue Recent Development
11.11 Boule Diagnostics
11.11.1 Boule Diagnostics Company Detail
11.11.2 Boule Diagnostics Business Overview
11.11.3 Boule Diagnostics Hematology Therapies Introduction
11.11.4 Boule Diagnostics Revenue in Hematology Therapies Business (2019-2024)
11.11.5 Boule Diagnostics Recent Development
11.12 EKF Diagnostics
11.12.1 EKF Diagnostics Company Detail
11.12.2 EKF Diagnostics Business Overview
11.12.3 EKF Diagnostics Hematology Therapies Introduction
11.12.4 EKF Diagnostics Revenue in Hematology Therapies Business (2019-2024)
11.12.5 EKF Diagnostics Recent Development
11.13 Drew Scientific
11.13.1 Drew Scientific Company Detail
11.13.2 Drew Scientific Business Overview
11.13.3 Drew Scientific Hematology Therapies Introduction
11.13.4 Drew Scientific Revenue in Hematology Therapies Business (2019-2024)
11.13.5 Drew Scientific Recent Development
11.14 Mindray Medical
11.14.1 Mindray Medical Company Detail
11.14.2 Mindray Medical Business Overview
11.14.3 Mindray Medical Hematology Therapies Introduction
11.14.4 Mindray Medical Revenue in Hematology Therapies Business (2019-2024)
11.14.5 Mindray Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Hematology Therapies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hematology Instruments
Table 3. Key Players of Hematology Consumables
Table 4. Global Hematology Therapies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Hematology Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Hematology Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Hematology Therapies Market Share by Region (2019-2024)
Table 8. Global Hematology Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Hematology Therapies Market Share by Region (2025-2030)
Table 10. Hematology Therapies Market Trends
Table 11. Hematology Therapies Market Drivers
Table 12. Hematology Therapies Market Challenges
Table 13. Hematology Therapies Market Restraints
Table 14. Global Hematology Therapies Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Hematology Therapies Market Share by Players (2019-2024)
Table 16. Global Top Hematology Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematology Therapies as of 2023)
Table 17. Ranking of Global Top Hematology Therapies Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Hematology Therapies Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hematology Therapies Product Solution and Service
Table 21. Date of Enter into Hematology Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hematology Therapies Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Hematology Therapies Revenue Market Share by Type (2019-2024)
Table 25. Global Hematology Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Hematology Therapies Revenue Market Share by Type (2025-2030)
Table 27. Global Hematology Therapies Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Hematology Therapies Revenue Market Share by Application (2019-2024)
Table 29. Global Hematology Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Hematology Therapies Revenue Market Share by Application (2025-2030)
Table 31. North America Hematology Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Hematology Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Hematology Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Hematology Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Hematology Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Hematology Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Hematology Therapies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Hematology Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Hematology Therapies Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hematology Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Hematology Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Hematology Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Hematology Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Hematology Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Hematology Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Hematology Therapies Product
Table 49. Abbott Laboratories Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Bio-Rad Laboratories Company Detail
Table 52. Bio-Rad Laboratories Business Overview
Table 53. Bio-Rad Laboratories Hematology Therapies Product
Table 54. Bio-Rad Laboratories Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 55. Bio-Rad Laboratories Recent Development
Table 56. Roche Company Detail
Table 57. Roche Business Overview
Table 58. Roche Hematology Therapies Product
Table 59. Roche Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 60. Roche Recent Development
Table 61. HORIBA Company Detail
Table 62. HORIBA Business Overview
Table 63. HORIBA Hematology Therapies Product
Table 64. HORIBA Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 65. HORIBA Recent Development
Table 66. Beckman Coulter Company Detail
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Hematology Therapies Product
Table 69. Beckman Coulter Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. Bayer Company Detail
Table 72. Bayer Business Overview
Table 73. Bayer Hematology Therapies Product
Table 74. Bayer Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Sysmex Company Detail
Table 77. Sysmex Business Overview
Table 78. Sysmex Hematology Therapies Product
Table 79. Sysmex Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 80. Sysmex Recent Development
Table 81. Ortho Clinical Diagnostic Company Detail
Table 82. Ortho Clinical Diagnostic Business Overview
Table 83. Ortho Clinical Diagnostic Hematology Therapies Product
Table 84. Ortho Clinical Diagnostic Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 85. Ortho Clinical Diagnostic Recent Development
Table 86. Siemens Healthineers Company Detail
Table 87. Siemens Healthineers Business Overview
Table 88. Siemens Healthineers Hematology Therapies Product
Table 89. Siemens Healthineers Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 90. Siemens Healthineers Recent Development
Table 91. HemoCue Company Detail
Table 92. HemoCue Business Overview
Table 93. HemoCue Hematology Therapies Product
Table 94. HemoCue Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 95. HemoCue Recent Development
Table 96. Boule Diagnostics Company Detail
Table 97. Boule Diagnostics Business Overview
Table 98. Boule Diagnostics Hematology Therapies Product
Table 99. Boule Diagnostics Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 100. Boule Diagnostics Recent Development
Table 101. EKF Diagnostics Company Detail
Table 102. EKF Diagnostics Business Overview
Table 103. EKF Diagnostics Hematology Therapies Product
Table 104. EKF Diagnostics Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 105. EKF Diagnostics Recent Development
Table 106. Drew Scientific Company Detail
Table 107. Drew Scientific Business Overview
Table 108. Drew Scientific Hematology Therapies Product
Table 109. Drew Scientific Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 110. Drew Scientific Recent Development
Table 111. Mindray Medical Company Detail
Table 112. Mindray Medical Business Overview
Table 113. Mindray Medical Hematology Therapies Product
Table 114. Mindray Medical Revenue in Hematology Therapies Business (2019-2024) & (US$ Million)
Table 115. Mindray Medical Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hematology Therapies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hematology Therapies Market Share by Type: 2023 VS 2030
Figure 3. Hematology Instruments Features
Figure 4. Hematology Consumables Features
Figure 5. Global Hematology Therapies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Hematology Therapies Market Share by Application: 2023 VS 2030
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Academic Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Hematology Therapies Report Years Considered
Figure 12. Global Hematology Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Hematology Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Hematology Therapies Market Share by Region: 2023 VS 2030
Figure 15. Global Hematology Therapies Market Share by Players in 2023
Figure 16. Global Top Hematology Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematology Therapies as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Hematology Therapies Revenue in 2023
Figure 18. North America Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Hematology Therapies Market Share by Country (2019-2030)
Figure 20. United States Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Hematology Therapies Market Share by Country (2019-2030)
Figure 24. Germany Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Hematology Therapies Market Share by Region (2019-2030)
Figure 32. China Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Hematology Therapies Market Share by Country (2019-2030)
Figure 40. Mexico Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Hematology Therapies Market Share by Country (2019-2030)
Figure 44. Turkey Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Hematology Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 47. Bio-Rad Laboratories Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 48. Roche Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 49. HORIBA Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 50. Beckman Coulter Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 51. Bayer Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 52. Sysmex Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 53. Ortho Clinical Diagnostic Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 54. Siemens Healthineers Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 55. HemoCue Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 56. Boule Diagnostics Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 57. EKF Diagnostics Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 58. Drew Scientific Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 59. Mindray Medical Revenue Growth Rate in Hematology Therapies Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
